UPDATE 2-Lonza to buy U.S. capsule maker Capsugel for $5.5 bln

Dec 15 (Reuters) - Lonza Group AG will buy

Capsugel, a U.S. maker of capsule products and other drug

delivery systems, for $5.5 billion in cash, it said on Thursday,

in the Swiss pharmaceutical...

Read more